Cluster A included 21 patients grouped as highly vascularised tumours showing higher values of VEGFR2 [median 18,784 (IQR 17,579–21,842) pg/ml] and ANG2 [2062 (1296–3328) pg/ml] expression. The gene discussed is ANGPT2; the disease is neoplasm.